PHYSICIAN-GUIDED TREATMENT COMPARED WITH A HEPARIN PROTOCOL FOR DEEP-VEIN THROMBOSIS

被引:39
作者
ELLIOTT, CG
HILTUNEN, SJ
SUCHYTA, M
HULL, RD
RASKOB, GE
PINEO, GF
JENSEN, RL
YEATES, S
KITTERMAN, N
机构
[1] LATTER DAY ST HOSP,DEPT MED,SALT LAKE CITY,UT
[2] UNIV UTAH,SALT LAKE CITY,UT
[3] UNIV CALGARY,DIV GEN INTERNAL MED,CLIN TRIALS UNIT,CALGARY,AB,CANADA
关键词
D O I
10.1001/archinte.154.9.999
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Effective heparin therapy, defined by therapeutic prolongation of the activated partial thromboplastin time (APTT), decreases the risk of recurrent venous thromboembolism. Achieving therapeutic prolongation of the APTT within 24 hours of the start of heparin therapy has proved difficult. We hypothesized that a protocol that delivered high initial heparin infusions to patients without identifiable risk for bleeding complications would decrease the time to achieve a therapeutic anticoagulant effect without increasing the incidence of major bleeding complications. Methods: To test this hypothesis, we studied concurrent patient cohorts. We defined a therapeutic anticoagulant effect (APTT > 55 seconds) to be an APTT more than 1.5 times the upper limit of normal. Twenty patients with acute symptomatic deep vein thrombosis received a 5000-U heparin bolus, followed by 1680 U/h (low risk to bleed) or 1240 U/h (high risk to bleed), adjusted by protocol-directed response to APTT results. Forty-eight patients with deep vein thrombosis were treated by their physicians. The Kaplan-Meier method was used to examine the proportion of patients who achieved an APTT greater than 55 seconds as a function of time. Results: The two study cohorts did not differ with respect to age, weight, or risk factors for venous thromboembolism. Analysis of Kaplan-Meier curves showed that the heparin protocol decreased the time to achieve a therapeutic anticoagulant effect (P = .025). Ten (91%) of 11 patients (95% confidence interval, 59% to 100%) without risks to bleed who were treated by the heparin protocol and 29 (60%) of 48 patients (95% confidence interval, 45% to 74%) not treated by the protocol had an initial therapeutic APTT (P = .006). Conclusion: A protocol that delivers higher initial heparin infusions to patients without identifiable risks for bleeding decreases the time needed to achieve therapeutic prolongation of APTT, when compared with nonprotocol physician management.
引用
收藏
页码:999 / 1004
页数:6
相关论文
共 22 条
[1]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[2]  
BARRITT DW, 1960, LANCET, V1, P1309
[3]   ACENOCOUMAROL AND HEPARIN COMPARED WITH ACENOCOUMAROL ALONE IN THE INITIAL TREATMENT OF PROXIMAL-VEIN THROMBOSIS [J].
BRANDJES, DPM ;
HEIJBOER, H ;
BULLER, HR ;
DERIJK, M ;
JAGT, H ;
TENCATE, JW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1485-1489
[4]   ESTABLISHING A THERAPEUTIC RANGE FOR HEPARIN-THERAPY [J].
BRILLEDWARDS, P ;
GINSBERG, JS ;
JOHNSTON, M ;
HIRSH, J .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :104-109
[5]  
CIPALLE RJ, 1981, CLIN PHARMACOL THER, V29, P387
[6]   A STANDARD HEPARIN NOMOGRAM FOR THE MANAGEMENT OF HEPARIN-THERAPY [J].
CRUICKSHANK, MK ;
LEVINE, MN ;
HIRSH, J ;
ROBERTS, R ;
SIGUENZA, M .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (02) :333-337
[7]   AUDIT OF CONTROL OF HEPARIN TREATMENT [J].
FENNERTY, AG ;
THOMAS, P ;
BACKHOUSE, G ;
BENTLEY, P ;
CAMPBELL, IA ;
ROUTLEDGE, PA .
BRITISH MEDICAL JOURNAL, 1985, 290 (6461) :27-28
[8]   HEPARIN KINETICS IN VENOUS THROMBOSIS AND PULMONARY-EMBOLISM [J].
HIRSH, J ;
VANAKEN, WG ;
GALLUS, AS ;
DOLLERY, CT ;
CADE, JF ;
YUNG, WL .
CIRCULATION, 1976, 53 (04) :691-695
[9]  
HULL R, 1979, NEW ENGL J MED, V301, P855, DOI 10.1056/NEJM197910183011602
[10]   HEPARIN FOR 5 DAYS AS COMPARED WITH 10 DAYS IN THE INITIAL TREATMENT OF PROXIMAL VENOUS THROMBOSIS [J].
HULL, RD ;
RASKOB, GE ;
ROSENBLOOM, D ;
PANJU, AA ;
BRILLEDWARDS, P ;
GINSBERG, JS ;
HIRSH, J ;
MARTIN, GJ ;
GREEN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (18) :1260-1264